The envelope of influenza A viruses contains two major glycoproteins: haemagglutinin (HA) and neuraminidase (NA). HA plays a crucial role in virus entry and is an important target for neutralizing antibodies. As yet, 16 different HA subtypes have been detected in avian influenza viruses (AIVs). Immune sera directed against one subtype normally do not show cross-neutralizing activity against other subtypes. The antigenic drift within a subtype is an important mechanism by which influenza A viruses escape neutralization by antibodies. NA is a sialidase which removes the receptor determinant from cellular and viral glycoproteins, and facilitates release of progeny viruses from the host cell (Palese et al., 1974) . At present, nine different NA subtypes have been found in AIVs.
Highly pathogenic AIVs (HPAIVs) are characterized by a multi-basic cleavage site in HA which is recognized by furin and related prohormone convertases (Klenk & Garten, 1994) . The ubiquitous expression of these enzymes promotes systemic infection of the host. HPAIVs cause a devastating, economically important disease in domestic poultry. In addition, they pose a considerable threat to public health as exemplified by the numerous fatal cases of human infections with H5N1 in the past. Although H5N1 was not transmitted between humans, further adaptation of these viruses or reassortment with human or porcine influenza viruses may eventually lead to viruses with pandemic potential (Herfst et al., 2012; Imai et al., 2012; Zhang et al., 2013) . This risk is not unrealistic as H5N1 viruses continue to circulate and evolve in South-East Asia, leading to new phylogenetic clades and subclades. Recently, human cases of infection with H7N9 demonstrated that the zoonotic potential of AIVs is not restricted to HPAIVs .
The ongoing evolution of H5N1 highlights the importance of serological surveillance programmes. In addition, the serological relatedness between available vaccines and currently circulating viruses must be determined. However, handling of AIVs with zoonotic potential requires highlevel biosafety containment. An attractive alternative is the pseudotyping of harmless viruses with the envelope glycoproteins of zoonotic influenza viruses, as the resulting surrogate viruses can be safely used for detection of neutralizing antibodies. Vesicular stomatitis virus (VSV; family Rhabdoviridae), a non-segmented negative-strand RNA virus, is known to incorporate foreign viral glycoproteins in a rather unselective manner (Schnell et al., 1996) . Influenza virus HA is also incorporated into recombinant VSV particles (Kretzschmar et al., 1997) ; however, expression of HA in place of the homotypic VSV glycoprotein did not result in propagation-competent pseudotype virus (Kalhoro et al., 2009 ). The present study aimed at pseudotyping VSV with the two major influenza virus glycoproteins HA and NA. The recombinant viruses were analysed with respect to incorporation of the foreign viral glycoproteins, competence for autonomous propagation and antibody-mediated neutralization. and RNA polymerase (L) (Fig. 1a) . In previous studies, VSV was genetically commuted into VSV*, which expresses GFP from an additional transcription unit (Schnell et al., 1996) . VSV* was further modified by replacing the G gene with either the HA or NA gene of HPAIV A/chicken/Yamaguchi/ 7/2004 (H5N1) (Halbherr et al., 2013) . The resulting viruses VSV*DG(HA H5 ) and VSV*DG(NA N1 ) were propagated on helper cells providing the VSV glycoprotein in trans (Hanika et al., 2005) . In addition, a VSV vector with seven transcription units was generated to allow the expression of HA and NA together with GFP. VSV*DG is a single-cycle vector which cannot spread in non-complementing cells (Takada et al., 1997) . Likewise, VSV*DG(NA N1 ) remained confined to primary infected cells 18 h after infection of BHK-21 cells at m.o.i. 0.01 (Fig.  2a) . Infection with VSV*DG(HA H5 ) and VSV*DG(HA H7 ) led to the formation of fluorescent cell foci, indicating that HA mediated a slow cell-to-cell spread of the vector. When HA H5 or HA H7 were expressed together with NA N1 from the same vector, the whole cell monolayer became positive for GFP at 18 h p.i., suggesting that virus spread was greatly enhanced by NA.
To further analyse the capacity of the recombinant viruses to propagate on non-helper cells, MDCK cells were infected at m.o.i. 0.01. At different times, cell culture supernatant was collected and infectious virus titres determined (Fig. 2b) . No infectious virus was detected in the medium of cells infected with either VSV*DG, VSV*DG(NA N1 ) or VSV*DG(HA H5 ). In contrast, VSV*DG(HA H5 ,NA N1 ) and VSV*DG(HA H7 ,NA N1 ) were released from infected cells, leading to increasing infectious titres with time reaching 10 7 focus-forming units (f.f.u.) ml 21 at 36 h p.i. These results indicate that while HA H5 can mediate cell-to-cell spread of the vector, co-expression of NA is essential for (Fig. 2d) . We believe that this strategy might be useful to further enhance the biosafety of the pseudotype viruses.
The influenza virus HA and the VSV G glycoprotein exhibit similar functions, namely binding to cellular receptor determinants and membrane fusion in a pH-dependent manner. Despite this similarity, expression of HA from a VSVDG genome did not result in propagation-competent virus. Although infectious progeny was not released into the cell culture supernatant, a slow spread of VSV*DG(HA) from cell to cell was observed, which is reminiscent of the previously described HA-mediated cell-to-cell transmission of influenza virus (Mori et al., 2011) . Propagationcompetent pseudotype virus was achieved only when NA was expressed together with HA, illustrating the importance of NA as a release factor of influenza viruses. It has been shown previously that HA and NA of A/WSN/33 (H1N1) are incorporated into VSV particles (Kretzschmar et al., 1997) . In agreement with this observation, Western blot analysis demonstrated the presence of HA H5 , HA H7 and NA N1 in VSV*DG(HA H5 ,NA N1 ) and VSV*DG(HA H7 ,NA N1 ), respectively.
The M2 ion channel protein has been proposed to play a role in virus uncoating as well as in HA maturation by preventing a premature conformational change of the glycoprotein in acidic compartments of the secretory pathway (Schnell & Chou, 2008) . This function of M2 was suggested to be particularly necessary for HPAIVs because these viruses are proteolytically activated in the trans-Golgi network. Anti-VSV 64 000
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Anti-H5 (clade 1.1) (Alberini et al., 2009; Ao et al., 2008; Tsai et al., 2009; Wang et al., 2008 Wang et al., , 2010 . These vectors are propagationincompetent and need to be produced repeatedly by transfection of mammalian cells with a set of plasmids -a cumbersome and expensive procedure. In contrast, the VSV pseudotypes can be propagated on conventional mammalian cell lines and easily standardized according to their infectious titre. Insertional mutagenesis, an inherent risk associated with retroviral vectors, can be excluded since VSV replicates exclusively in the cytosol.
VSV has the potential to infect humans (Fields & Hawkins, 1967) . Nevertheless, recombinant propagation-competent VSV pseudotypes expressing the glycoprotein of Ebola virus, a highly virulent haemorrhagic fever virus, were shown to be safe in monkeys and in a human case of emergency vaccination (Geisbert et al., 2008; Günther et al., 2011) . This suggests that pseudotyping of VSV with envelope glycoproteins of highly virulent viruses does not necessarily render VSV more virulent. Furthermore, propagation-competent VSV might be attenuated using a mutant M protein which is unable to suppress nucleocytoplasmic RNA transport (Hoffmann et al., 2010) . As a consequence, cells infected with these mutant viruses will induce IFN, which hinders virus dissemination by inducing an antiviral state in cells.
In summary, we presented a new viral pseudotype system, which allows safe, fast, sensitive and accurate detection of neutralizing antibodies against influenza viruses. These viruses might also be useful for screening of entry inhibitors, and for studying influenza virus receptor usage and tropism.
